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Abstract 
 
We characterized DNA methylation quantitative trait loci (mQTLs) in a large collection 
(n=166) of human fetal brain samples spanning 56-166 days post-conception, identifying 
>16,000 fetal brain mQTLs. Fetal brain mQTLs are primarily cis-acting, enriched in 
regulatory chromatin domains and transcription factor binding sites, and show significant 
overlap with genetic variants also associated with gene expression in the brain. Using tissue 
from three distinct regions of the adult brain (prefrontal cortex, striatum and cerebellum) we 
show that most fetal brain mQTLs are developmentally stable, although a subset is 
characterized by fetal-specific effects. We show that fetal brain mQTLs are enriched amongst 
risk loci identified in a recent large-scale genome-wide association study (GWAS) of 
schizophrenia, a severe psychiatric disorder with a hypothesized neurodevelopmental 
component. Finally, we demonstrate how mQTLs can be used to refine GWAS loci through 
the identification of discrete sites of variable fetal brain methylation associated with 
schizophrenia risk variants.         
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Human brain development is orchestrated by complex transcriptional programs1, which are 
guided and reinforced by epigenetic modifications to DNA and histone proteins. DNA 
methylation is the most extensively studied epigenetic modification, playing a key role in 
many important genomic regulatory processes2. Of note, the establishment and maintenance 
of cell- and tissue-specific DNA methylation patterns is crucial for normal mammalian 
development3. Although traditionally regarded as a mechanism of transcriptional repression, 
DNA methylation can be associated with both increases and decreases in gene expression4, 
and has recently been implicated in other genomic functions including alternative splicing and 
promoter usage5.  
 
We recently characterized widespread changes in DNA methylation across human fetal brain 
development6, although the factors influencing inter-individual methylomic variation during 
the prenatal period are unknown. Studies in a variety of tissues, including adult human 
brain7,8, have shown that DNA methylation can be influenced by DNA sequence variation. 
These methylation quantitative trait loci (mQTLs) have been found to overlap with DNA 
variants associated with levels of gene expression (expression quantitative trait loci; 
eQTLs)4,9, and may serve as markers for these as well as other genetic influences on gene 
regulation. Although mQTLs have previously been assessed in the adult human brain using 
low-resolution DNA methylation arrays7,8, mQTLs in the developing human brain have not 
previously been explored.  
 
In this study we combine high-density DNA methylation profiling with genome-wide SNP 
genotyping in a large (n = 166) collection of human brain samples from the first and second 
trimester of gestation. Given the growing evidence that many common variants associated 
with complex diseases act through effects on gene regulation10,11, we subsequently test for 
enrichment of fetal mQTL amongst risk loci identified in a recent large-scale GWAS of 
schizophrenia12, a neuropsychiatric disorder with a hypothesized neurodevelopmental 
component13,14. Finally, we show how mQTL data can be used to refine broad GWAS loci 
through the identification of discrete sites of variable fetal brain methylation associated with 
schizophrenia risk variants. As a resource to the wider community we have developed a 
searchable online database of fetal brain mQTLs that can be accessed at 
http://epigenetics.essex.ac.uk/mQTL/.   
 
 
Results 
Methylation quantitative trait loci (mQTL) in the developing human brain are widespread 
and predominantly characterized by cis effects: 
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We performed genome-wide single nucleotide polymorphism (SNP) genotyping and DNA 
methylation profiling in 166 human fetal brain samples ranging from 56 to 166 days post-
conception (see Online Methods and Supplementary Table 1). After stringent quality-
control we tested for an additive effect of allele dosage on DNA methylation across all 
potential pairings of 430,304 SNPs and 314,554 DNA methylation sites to identify fetal brain 
mQTLs (Supplementary Table 1). We identified 16,809 mQTLs at a conservative 
Bonferroni-corrected significance threshold of P < 3.69x10-13 (Supplementary Tables 2 and 
3). The median DNA methylation change per allele across all identified mQTLs was 6.69% 
(interquartile range (IQR) = 3.17%-8.96%) for each mQTL SNP (Supplementary Fig. 1), 
slightly larger than reported in a previous analysis of genome-wide mQTLs in the adult brain 
(median effect size = 4.11%, IQR = 2.13-6.97%)7. The majority of mQTL SNPs (74.17%) are 
associated with DNA methylation at only a single probe; in contrast, most DNA methylation 
sites (69.83%) showing evidence for association do so with multiple mQTL SNPs, 
presumably as a result of linkage disequilibrium (LD) between SNPs (Supplementary Fig. 
2). A searchable database of fetal brain mQTLs is available at: 
http://epigenetics.essex.ac.uk/mQTL/.   
 
The majority of fetal brain mQTLs (96.3%) involve SNPs and DNA methylation sites on the 
same chromosome (Fig. 1a and Supplementary Table 2). We defined significant SNP-
methylation relationships spanning <500kb as “cis-mQTLs” (n = 15,942, 94.8% of total), 
with those spanning >500kb or characterized by inter-chromosomal effects (n = 867, 5.16% 
of total) as representing trans-mQTLs. The strong enrichment of cis-mQTLs concurs with 
data from other tissues and cell-types7,15-18. Amongst the cis-mQTLs, both effect size (i.e. 
DNA methylation change per allele, Fig. 1b) and significance (i.e. P-value, Supplementary 
Fig. 3) are related to the distance between the Illumina 450K array probe and mQTL SNP.  
 
Despite the preponderance of cis-mQTLs, there are some notable trans-mQTL effects (Fig. 
1c and Supplementary Table 4), consistent with previous reports of long-range genetic 
regulation of epigenetic variation in multiple cell-types19. Although the average effect size for 
trans-mQTLs is significantly lower than that observed for cis-mQTLs (two-sided Wilcoxon 
rank sum test, P = 6.74x10-7) (Supplementary Fig. 1), there is a higher proportion of larger 
(DNA methylation change per allele > 25%) effects among trans-mQTLs than cis-mQTLs 
(1.04% vs 0.715%). Of the 178 DNA methylation sites identified as being associated with 
trans-acting genetic variation in the fetal brain, 50 (28.09%) and 108 (60.67%) were also 
identified in studies of pancreatic islet cells16 and lymphocytes19, respectively 
(Supplementary Table 4 and Supplementary Table 5). These long-range associations 
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between genotype and DNA methylation complement data showing interactions between 
regulatory elements spanning several Mb20, and even between chromosomes21. 
 
Fetal brain mQTLs are significantly enriched in functional regulatory domains: 
We used data from ENCODE and the Roadmap Epigenomics Project10,22-24 to assess whether 
sites characterized by genotype-associated DNA methylation co-localize with genomic 
regions associated with markers of transcriptional activity. We observed an enrichment of 
fetal brain mQTLs in genomic regions characterized by ChIP-seq peaks for repressive histone 
modifications in fetal brain – for example, H3K9me3 (relative enrichment = 1.43, P = 
0.00107) and H3K27me3 (relative enrichment = 1.16, P = 0.000144) - and a significant 
depletion of fetal brain mQTLs in genomic regions defined by ChIP-seq peaks for histone 
modifications associated with active transcription – for example, H3K4me1 (relative 
enrichment = 0.828, P = 6.55x10-8) and H3K36me3 (relative enrichment = 0.543, P = 
1.39x10-15 (Supplementary Table 6). Fetal brain mQTLs were found to be significantly 
enriched in regions of open chromatin indicated by DNase1 hypersensitivity sites (DHSs) 
identified in the adult human brain (Supplementary Table 7), consistent with the observation 
that intermediately methylated domains, one potential consequence of allele-specific DNA 
methylation, are enriched in DHSs25. We also identified a significant enrichment of genotype-
associated DNA methylation sites overlapping annotated transcription factor binding sites 
identified by the ENCODE project10,26 (relative enrichment = 1.26, P = 2.96x10-11) 
(Supplementary Table 8). Of note, there is a highly-significant enrichment (odds ratio = 
1.35, P = 1.66x10-9) of fetal brain mQTLs influencing DNA methylation in CCCTC-binding 
factor (CTCF) motifs (Supplementary Table 8), confirming a finding from a previous study 
of heritable DNA methylation sites in the human brain27. CTCF is an 11 zinc-finger protein 
with insulator and chromatin barrier activity whose binding affinity is known to be strongly 
influenced by DNA methylation28. Given the important role of CTCF in core genomic 
processes including transcription, chromosomal interactions and chromatin structure29, the 
enrichment of genetically-mediated DNA methylation at CTCF binding sites highlights an 
important potential mechanism linking genetic variation to genomic function. In addition to 
CTCF, a significant enrichment was also observed within binding sites for several other 
transcription factors, including IRF1, GABP, ELF1, Rad21 and CCNT2, with significant 
depletion in binding sites for others (e.g. SUZ12, CtBP2)  (Supplementary Table 8).  
 
Although the majority of fetal brain mQTLs are conserved in adult brain regions, there are 
fetal-specific genetic effects on DNA methylation at certain loci:  
We next generated mQTL data from three adult human brain regions (prefrontal cortex 
(PFC), striatum (STR) and cerebellum (CER)) dissected from matched donors (n = 83; 21-96 
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years old, see Online Methods and Supplementary Table 1) to explore the extent to which 
fetal brain mQTLs are also present in the adult brain. Using a replication mQTL significance 
threshold of P < 1x10-5, the majority (83.46%) of fetal brain mQTLs are present in at least 
one of the tested adult brain region (Supplementary Table 9 and Fig. 2a), and there is a 
highly-significant overall correlation of individual mQTL effect sizes between fetal brain and 
each of the individual adult brain regions (PFC: r = 0.911, P < 2.2x10-16; STR: r = 0.899, P < 
2.2x10-16; CER: r = 0.835, P < 2.2x10-16) (Supplementary Fig. 4) across all Bonferroni-
significant fetal brain mQTLs, even in mQTLs that do not meet our replication threshold 
(Supplementary Fig. 5). Of note, fetal brain mQTLs that do not replicate in adult brain are 
characterized by significantly lower effect sizes across all brain regions, including the fetal 
brain discovery sample (P = 3.18x10-141) (Supplementary Fig. 6). Despite the overall strong 
concordance in the direction of mQTL effects between fetal and adult brain, there are notable 
examples of heterogeneity between fetal and adult brain tissue. We used a multilevel linear 
regression model to test the significance of an interaction term and identify differential mQTL 
effects across our datasets. Of the 10,663 fetal mQTL effects tested, 3,173 (29.76%) were 
found to be significantly heterogeneous (Bonferroni-corrected P < 4.69 x 10-6) across the fetal 
and adult datasets (Supplementary Table 10). These include mQTLs that had notably larger 
or notably smaller effects in the adult brain, and fetal-specific mQTLs showing no significant 
association with DNA methylation in any adult brain region (see Fig. 2b). We also identified 
a small number (n = 45) of fetal brain mQTLs that had opposite effects on DNA methylation 
in fetal and adult brain samples (Fig. 2c and Supplementary Table 11). 
 
Fetal brain mQTLs overlap with genetic variants associated with RNA transcript abundance 
in the brain: 
We used eQTL data from ten adult brain regions30 to test whether identified fetal brain 
mQTLs overlap with genetic variants associated with RNA transcript abundance in cis. We 
compared the distribution of the minimum brain eQTL P-value of all interrogated SNPs split 
into the subsets of those identified as fetal brain mQTLs and those not (Supplementary Fig. 
7), finding that variants associated with DNA methylation are indeed more likely to be 
associated with gene expression in cis (Wilcoxon rank sum test P < 2.2x10-16). Of the 414,172 
SNPs tested in both the mQTL and eQTL datasets, 9,869 were identified as being Bonferroni-
significant cis mQTLs and 2,674 as Bonferroni-significant (P < 5.99x10-9) eQTLs, with an 
overlap of 750 variants associated with 227 DNA methylation probes and 127 transcript 
probes (Supplementary Table 12). At a more relaxed eQTL threshold (P < 1.00x10-7), there 
is an overlap of 1,042 variants associated with 315 DNA methylation probes and 183 
transcript probes. A list of all variants associated with both DNA methylation and gene 
expression in cis is given in Supplementary Table 13. This overlapping set of variants likely 
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includes multiple SNPs in LD that are associated with one gene expression transcript and 
DNA methylation site. Because the extent and magnitude of LD varies across the genome, we 
established an LD-independent set of SNPs associated with DNA methylation and tested the 
overlap of these with the sentinelized subsignals – i.e. the most associated marker from a set 
in high LD (r2 > 0.8) - from the brain eQTL dataset30. Compared to 1 million simulated 
mQTL SNP sets matched for allele frequency, this overlap was significantly greater than 
expected (relative enrichment = 4.23, P < 1.00x10-6 after 1 million simulations; 
Supplementary Table 14 and Supplementary Fig. 8).  
 
There is a significant enrichment of schizophrenia-associated GWAS variants in fetal brain 
mQTLs: 
Our catalogue of fetal brain mQTLs provides a unique resource for investigating putative 
functional consequences of genetic variation associated with postulated neurodevelopmental 
disorders such as schizophrenia. A recent large-scale GWAS identified 108 independent 
genomic loci exhibiting genome-wide significant association with the disorder (P < 5x10-8), 
with evidence for a substantial polygenic component within signals that fall below this 
stringent level of significance12. Because the majority of these variants reside in regions of 
strong LD and do not index coding variants affecting protein structure, there remains 
considerable uncertainty about the causal genes involved in pathogenesis and the way in 
which they are functionally regulated by schizophrenia risk variants. We used PLINK31 to 
‘clump’ our list of significant (P < 3.69x10-13) fetal brain mQTL variants into a set of quasi-
independent SNPs (SNP pairwise r2 < 0.25 within 250kb (non-major histocompatibility 
complex (MHC)) or 10000kb (MHC)), see Online Methods) and tested for enrichment of 
schizophrenia-associated variants across a range of GWAS significance-thresholds, using up 
to 1,000,000 simulated SNP sets to generate empirical P values (see Online Methods). We 
observed a highly-significant enrichment (relative enrichment = 4.11, P = 3.0x10-6) of 
genome-wide significant schizophrenia risk variants amongst fetal brain mQTLs, with a trend 
for stronger enrichment at more stringent levels of GWAS significance (Supplementary Fig. 
9 and Table 1). To examine the specificity of any enrichment, these analyses were repeated 
using large GWAS datasets from i) a non-neurodevelopmental brain disorder (Alzheimer’s 
disease (AD)32) and ii) two non-neurological phenotypes (body mass index (BMI)33 and type 
2 diabetes (T2D)34. Although our confidence in the enrichment of fetal brain mQTL in these 
datasets is limited by the smaller number of semi-independent GWAS SNPs, levels of 
enrichment were found to be notably lower for all other tested phenotypes (Table 1). Variants 
associated with AD are, however, nominally significantly enriched at the most relaxed 
GWAS threshold (GWAS threshold P < 5x10-5: relative enrichment = 3.18, P = 0.022) and 
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several individual GWAS variants identified for this and the other tested phenotypes are also 
significant mQTLs in fetal brain mQTLs (Supplementary Table 15).  
 
The identified mQTLs residing in schizophrenia-associated GWAS regions do not necessarily 
represent the actual causal risk variants; in many instances we are likely to be capturing 
‘passenger’ effects whereby the variant influencing DNA methylation and the schizophrenia-
associated SNP are instead co-segregating in the same LD block. Therefore we sought to 
identify instances where a likely causal risk variant for schizophrenia was an mQTL SNP. We 
used 1000 Genomes Project data (http://www.1000genomes.org/) to identify all variants in 
strong LD (r2 > 0.8) with the 125 autosomal index SNPs associated with schizophrenia12. Of 
note, two of the actual schizophrenia GWAS index SNPs represent Bonferroni-significant 
fetal brain mQTLs: rs2535627 (associated with DNA methylation at cg11645453, P = 
3.05x10-13, Supplementary Fig. 10) and rs4648845 (associated with DNA methylation at 
cg02275930, P = 4.54x10-15, Supplementary Fig. 11). 46 additional mQTL variants that are 
in strong LD with another six index SNPs are part of 86 highly-significant fetal brain mQTL 
pairs (Supplementary Table 16).  
 
mQTLs can be used to localize putative causal loci within large genomic regions associated 
with schizophrenia: 
To generate a more comprehensive database of mQTLs in the fetal brain and identify more 
examples where the same SNP is associated with both DNA methylation and disease, we 
imputed our genotype data using the most recent panel downloaded from the 1000 Genome 
Project (see Online Methods). Using an imputed set of 5,177,320 variants we identified an 
additional 256,040 mQTLs, which reflected the non-imputed dataset in terms of genomic 
distribution and observed effect sizes (Supplementary Table 2 and Supplementary Fig. 12). 
The full list of fetal brain mQTLs after imputation can be downloaded from: 
http://epigenetics.essex.ac.uk/mQTL//All_Imputed_BonfSignificant_mQTLs.csv.gz. Our 
imputed data enabled us to identify 1,067 instances where the same SNP is associated with 
both DNA methylation and schizophrenia, with a comprehensive list available for download 
from: 
http://epigenetics.essex.ac.uk/mQTL//PGC_IndexSNPs_QTLs_Inc2PCs_AllTissues_MatchS
NPPosition.csv). Because they could be biased by the LD structure at associated loci the 
imputed mQTL data were not used for subsequent enrichment analyses, but they enabled us to 
further refine schizophrenia candidate regions and undertake co-localization analyses in order 
to identify variants associated with both DNA methylation and schizophrenia. We performed 
a Bayesian co-localization analysis35 across the 105 autosomal regions associated with 
schizophrenia12, spanning 19,378 DNA methylation sites included in our analysis. Instead of 
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focusing only on the intersection of significant variants associated with two phenotypes 
independently, this approach compares the pattern of association results from the 
schizophrenia GWAS and mQTL analyses across a region, combining the summary statistics 
into posterior probabilities for five hypotheses (see Online Methods). As this methodology 
assumes that the causal variant is present, or at least very well tagged, in the dataset, these co-
localization analyses were performed using our imputed fetal brain mQTL dataset. The 
posterior probabilities for 65 regions, involving 296 DNA methylation sites in 306 pairs, were 
supportive of a co-localized association signal for both schizophrenia and DNA methylation 
in that region (PP3+PP4 > 0.99; Supplementary Table 17). Twenty-six of these pairs 
(covering 15 regions associated with schizophrenia) had a higher posterior probability for 
both schizophrenia and DNA methylation being associated with the same causal variant 
(PP4/PP3 > 1), with 16 (10 regions) of these having sufficient support for them to be 
considered as ‘convincing’ (PP4/PP3 > 5) according to the criteria of Giambartolomei and 
colleagues35. Of note, three of these top-ranked pairs are annotated to the AS3MT locus within 
a robust schizophrenia-associated region on chromosome 10 (Supplementary Table 17). The 
utility of mQTL mapping for localizing putative causal loci associated with disease within 
this region is shown in Fig. 3, with additional examples for other schizophrenia-associated 
regions available on our website (http://epigenetics.essex.ac.uk/mQTL/). 
 
Schizophrenia-associated genomic regions are enriched for fetal-specific mQTLs: 
Given the hypothesized neurodevelopmental component to schizophrenia, we examined the 
extent to which the mQTLs overlapping with schizophrenia-associated variants are 
characterized by fetal-specific effects (Supplementary Table 16). Across the 78 mQTLs also 
tested in adult brain samples, overall effect sizes were significantly larger in fetal brain than 
all adult brain regions tested (Wilcoxon rank-sum test: PFC P = 0.0420, STR P = 0.00226, 
CER P = 0.00998) (Fig. 4). Our heterogeneity analysis highlighted 16 (20.5%) instances 
where significantly different relationships between genotype and DNA methylation are found 
across the adult and fetal datasets, with eight classed as fetal-specific variants (i.e. those not 
reaching our replication threshold (P < 1.00x10-5) in any adult brain region) and the 
remaining eight demonstrating smaller effects across the adult brain.  
 
Discussion 
To explore the functional consequences of genetic variation in the developing human brain, 
we characterized mQTLs in human fetal brain samples (spanning 56-166 days post-
conception), identifying over 16,000 associated pairs of SNPs and DNA methylation sites. 
We find that fetal brain mQTLs are significantly enriched in functional regulatory domains 
including DHSs, regions of repressive histone modifications, and specific transcription factor 
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binding sites across the genome, and show significant overlap with genetic variants 
influencing gene expression in the brain. Although the majority of fetal brain mQTLs appear 
to be conserved across adult brain regions, we find evidence for fetal-specific genetic effects 
at certain loci. Our data concur with findings from an independent study of cortical mQTLs 
across development [Jaffe et al, Nat Neuro, in press]; mQTL effects are highly consistent 
across both analyses (Supplementary Fig. 13) and largely conserved between fetal and adult 
brain. 
 
There is growing evidence that the majority of common variants associated with complex 
traits act through effects on gene regulation10,11. Our data add to a growing literature showing 
that DNA methylation is genetically influenced27, with mQTLs representing a potential 
mechanism linking genetic variation to complex phenotypes4,9,36,37. We find a significant 
enrichment of schizophrenia-associated GWAS variants in fetal brain mQTLs, indicating that 
common genetic variants conferring risk for schizophrenia are associated with altered DNA 
methylation in fetal human brain. The hypothesis that schizophrenia has an early 
neurodevelopmental component is supported by several lines of epidemiological and 
neuropathological evidence13,14. However, direct molecular evidence of schizophrenia risk 
factors operating in the fetal brain is scarce38,39. We have recently found that genomic loci that 
are differentially methylated between schizophrenia patients and unaffected controls in the 
adult brain are enriched at those undergoing dynamic changes in DNA methylation during 
human fetal brain development6,40. In the present study, we find that genetic variants 
exhibiting genome-wide significant association with schizophrenia12 show a four-fold 
enrichment amongst fetal brain mQTLs, directly implicating altered gene regulation during 
fetal brain development in the etiology of the disorder.   
 
To conclude, we report the first systematic analysis of genetically-mediated DNA methylation 
in the developing human brain. Our data support the hypothesis that a significant proportion 
of the genetic variants conferring schizophrenia risk have regulatory effects that become 
manifest early in the prenatal period, and demonstrate the utility of mQTL mapping for 
localizing putative causal loci associated with complex disease phenotypes within large 
genomic regions. As a resource to the wider community, we have developed a searchable 
online database of fetal brain mQTLs that can be accessed at 
http://epigenetics.essex.ac.uk/mQTL/.   
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Figure Legends 
 
Figure 1: mQTLs in the developing human brain are predominantly cis-acting with 
effect size related to distance, although notable trans-effects are also present. (a) The 
genomic distribution of Bonferroni significant (P = 3.69 x10-13) mQTLs in fetal brain, where 
the position on the x-axis indicates the location of Illumina 450K HumanMethylation array 
probes and the position on the y-axis indicates the location of informative SNPs. The color of 
the point corresponds to the difference in DNA methylation per allele compared to the 
reference allele, with the largest effects plotted in dark red. A clear positive diagonal can be 
observed demonstrating that the majority of mQTLs in fetal brain are associated with 
genotype in cis. (b) The relationship between mQTL effect size (DNA methylation change 
per allele) and distance between the Illumina 450K HumanMethylation array probe and 
informative SNPs in fetal brain, confirming the predominantly cis nature of mQTLs. A 
similar relationship is seen between mQTL significance and distance (see Supplementary 
Fig. 3). (c) Trans-mQTLs in the developing human brain. Shown are all Bonferroni 
significant (P = 3.69 x10-13) trans-mQTLs identified in fetal brain samples. The thickness of 
each line depicts association effect size, with color reflecting the chromosomal location of the 
mQTL SNP.  
 
Figure 2: Despite a highly-significant overall correlation of individual mQTL effects 
between fetal brain and adult brain regions, a subset of loci are characterized by fetal-
specific mQTLs. (a) Heatmap showing effect sizes in adult brain for all fetal brain mQTLs 
tested. Using a replication mQTL significance threshold of P < 1.00E-5, the majority 
(83.46%) of fetal brain mQTLs are present in at least one of the tested adult brain region. 
Despite the overall strong concordance in the direction of mQTL between fetal and adult 
brain, there are notable examples of heterogeneity in mQTL effects between fetal and adult 
brain tissue. Shown are examples of (b) a fetal-specific mQTL between rs10447470 and 
cg07900658 (heterogeneity P = 7.23E-40) and (c) an mQTL between rs2108854 and 
cg21577356 showing an opposite direction of effect in fetal brain and cerebellum 
(heterogeneity P = 8.39E-36). 
 
Figure 3: mQTL mapping can localize putative causal loci associated with disease. Co-
localization analyses yielded strong support for variants annotated to the AS3MT gene being 
associated with both schizophrenia and DNA methylation within a broad genomic region 
(chr10:104535135-105006335) identified in a recent GWAS analysis of schizophrenia12. All 
potential causal variants (r2 > 0.8 with index variant) present in the imputed mQTL dataset are 
indicated by vertical blue lines and all DNA methylation probes within each region by 
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vertical red lines. Bonferroni-significant mQTLs are indicated by black lines between the 
respective variant and DNA methylation probe, where the line width reflects the magnitude of 
the effect. Additional examples of fetal brain mQTLs in genomic regions showing genome-
wide significant association with schizophrenia are available on our website 
(http://epigenetics.essex.ac.uk/mQTL/). 
 
Figure 4: Fetal mQTLs in schizophrenia-associated regions have larger effects on DNA 
methylation during neurodevelopment than the in adult brain. For robustly-associated 
schizophrenia GWAS variants characterized by human fetal brain mQTLs (Supplementary 
Table 16), we compared effect sizes between fetal and adult brain. Effect sizes (red to blue) 
for the corresponding mQTLs in adult brain are significantly lower across all three adult brain 
regions tested (Wilcoxon rank-sum test:  PFC P = 0.0420, STR P = 0.00226, CER P = 
0.00998). The heterogeneity P-value for each mQTL is depicted by the green (high 
heterogeneity) to yellow (low heterogeneity) column. White indicates that the mQTL was not 
tested in the adult brain samples. 
 
